xhoi linearized pcep4  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Thermo Fisher xhoi linearized pcep4
    Xhoi Linearized Pcep4, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 95/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/xhoi linearized pcep4/product/Thermo Fisher
    Average 95 stars, based on 2 article reviews
    Price from $9.99 to $1999.99
    xhoi linearized pcep4 - by Bioz Stars, 2020-04
    95/100 stars

    Related Products / Commonly Used Together

    yb2/0 cells
    hkbdca2-122a2
    stable transfection

    Images

    Related Articles

    Clone Assay:

    Article Title: Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation pattern
    Article Snippet: The VK and VH fragments of 122A2 were then sequentially cloned into the optimized HKgenEFss expression vector (LFB) allowing the expression of full-length IgG1 using SpeI/XbaI and NheI/AscI cloning site, respectively. .. The final vector, HKBDCA2-122A2, was used for the stable transfection of YB2/0 cells (LFB EMABling® platform REF U.S. Patent 8,409,572)., Each resulting coding sequence was inserted independently by infusion into the XhoI linearized pCEP4 (Invitrogen) expression vector, leading to pCEP4-122A2H and pCEP4-122A2K.

    Stable Transfection:

    Article Title: Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation pattern
    Article Snippet: .. The final vector, HKBDCA2-122A2, was used for the stable transfection of YB2/0 cells (LFB EMABling® platform REF U.S. Patent 8,409,572)., Each resulting coding sequence was inserted independently by infusion into the XhoI linearized pCEP4 (Invitrogen) expression vector, leading to pCEP4-122A2H and pCEP4-122A2K. .. YB2/0 clones were generated and screened for the best producers of IgG ch122A2.

    Generated:

    Article Title: Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation pattern
    Article Snippet: The final vector, HKBDCA2-122A2, was used for the stable transfection of YB2/0 cells (LFB EMABling® platform REF U.S. Patent 8,409,572)., Each resulting coding sequence was inserted independently by infusion into the XhoI linearized pCEP4 (Invitrogen) expression vector, leading to pCEP4-122A2H and pCEP4-122A2K. .. YB2/0 clones were generated and screened for the best producers of IgG ch122A2.

    Expressing:

    Article Title: Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation pattern
    Article Snippet: .. The final vector, HKBDCA2-122A2, was used for the stable transfection of YB2/0 cells (LFB EMABling® platform REF U.S. Patent 8,409,572)., Each resulting coding sequence was inserted independently by infusion into the XhoI linearized pCEP4 (Invitrogen) expression vector, leading to pCEP4-122A2H and pCEP4-122A2K. .. YB2/0 clones were generated and screened for the best producers of IgG ch122A2.

    Sequencing:

    Article Title: Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation pattern
    Article Snippet: .. The final vector, HKBDCA2-122A2, was used for the stable transfection of YB2/0 cells (LFB EMABling® platform REF U.S. Patent 8,409,572)., Each resulting coding sequence was inserted independently by infusion into the XhoI linearized pCEP4 (Invitrogen) expression vector, leading to pCEP4-122A2H and pCEP4-122A2K. .. YB2/0 clones were generated and screened for the best producers of IgG ch122A2.

    Recombinant:

    Article Title: Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation pattern
    Article Snippet: Ch122A2 mAb is a recombinant and chimeric antibody that targets the ectodomain of CD303. .. The final vector, HKBDCA2-122A2, was used for the stable transfection of YB2/0 cells (LFB EMABling® platform REF U.S. Patent 8,409,572)., Each resulting coding sequence was inserted independently by infusion into the XhoI linearized pCEP4 (Invitrogen) expression vector, leading to pCEP4-122A2H and pCEP4-122A2K.

    Plasmid Preparation:

    Article Title: Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation pattern
    Article Snippet: .. The final vector, HKBDCA2-122A2, was used for the stable transfection of YB2/0 cells (LFB EMABling® platform REF U.S. Patent 8,409,572)., Each resulting coding sequence was inserted independently by infusion into the XhoI linearized pCEP4 (Invitrogen) expression vector, leading to pCEP4-122A2H and pCEP4-122A2K. .. YB2/0 clones were generated and screened for the best producers of IgG ch122A2.